The global stroke post processing software market size surpassed USD 192.61 million in 2023 and is estimated to increase from USD 208.43 million in 2024 to approximately USD 458.81 million by 2034. It is projected to grow at a CAGR of 8.21% from 2024 to 2034.
The global stroke post processing software market size is expected to be worth USD 208.43 million in 2024 and is anticipated to reach around USD 458.81 million by 2034, growing at a solid CAGR of 8.21% over the forecast period 2024 to 2034. The North America stroke post processing software market size accounted for USD 97.96 million in 2024. The rising demand for healthcare software across the world is driving the growth of the stroke post processing software market.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
U.S. Stroke Post Processing Software Market Size and Growth 2024 to 2034
The U.S. stroke post processing software market size was exhibited at USD 42.55 million in 2023 and is projected to be worth around USD 103.52 million by 2034, poised to grow at a CAGR of 8.41% from 2024 to 2034.
North America held the largest share of the stroke post processing software market in 2023. The growth of the market in this region is mainly driven by the rising demand for stroke post-processing software from several famous hospitals that deal in the treatment of stroke, such as Cleveland Clinic, St Jude Children's Research Hospital, UC Davis Health, Johns Hopkins Medicine, Mayo Clinic Scottsdale AZ and some others. The growing developments in the healthcare industry in countries such as the U.S. and Canada, along with rising government investments to develop the IT industry and AI sector across this region, have boosted the market growth to some extent.
Moreover, presence of several local market players in stroke post-processing software, such as viz.ai, ISchemaView, Inc, CerebraAI, and some others, are continuously engaged in developing advanced stroke post-processing software for stroke detection and adopting several strategies such as partnerships, collaborations, and business expansions, which in turn drives the growth of the stroke post processing software market in this region.
Asia-Pacific is expected to be the fastest-growing region during the forecast period. The rising developments in the medical devices industry, along with superior healthcare facilities across the region, boost the market growth. Moreover, the presence of several renowned hospitals in countries such as India, China, Japan, South Korea, and some others that are engaged in stroke diagnosis and treatment has increased the demand for stroke post processing software in hospitals for use in MRI and CT scanners, which in turn is driving the market growth.
Additionally, various local companies of stroke post-processing software, such as Aidoc, Qure.ai, Infervision, and some others, are developing advanced software to fulfill the demand from hospitals treating stroke patients across the Asia Pacific region, which in turn is expected to drive the growth of the stroke post processing software market in this region.
The stroke post processing software market is one of the important industries in the healthcare sector. This industry mainly deals with the development of stroke post-processing software around the globe. This software can be installed on desktop and mobile phones & tablets. It is developed for various modalities, including MRI and CT scans. This software finds application in the detection of various kinds of strokes, including ischemic stroke, hemorrhagic Stroke, and some others. There are several end-users of the stroke post processing software industry that mainly include hospitals & clinics and specialty centres & others. This industry is expected to grow exponentially with the growth in the IT and healthcare industries.
Report Coverage | Details |
Market Size by 2034 | USD 458.81 Million |
Market Size in 2023 | USD 192.61 Million |
Market Size in 2024 | USD 208.43 Million |
Market Growth Rate from 2024 to 2034 | CAGR of 8.21% |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | Installation, Modality, Type, End-use, and Regions |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Rising demand for advanced medical software
Rapid developments are taking place in the healthcare industry. The integration of modern technologies has changed the landscape of the diagnosis and treatment methodologies for various diseases. The cases of different types of strokes are increasing daily in various parts of the world, and they require proper diagnosis and treatment to be cured. With the rising cases of strokes, hospitals and other treatment centers require superior devices that are accurate and efficient so as to diagnose and treat all patients in a shorter period of time. This, in turn, increases the demand for advanced stroke post-processing software, thereby driving the market growth.
The stroke post processing software market is a consolidated industry. There are a few dominating players, along with several new entrants in the market. Some of the prominent market players include Brainomix, Aidoc, RapidAI, Viz.Ai, Inc., CerebraAI, and others that are continuously engaged in developing advanced software for stroke detection and adopting several strategies to maintain their dominance in the industry.
Restraint
Security-related issues and malfunctioning
The applications of stroke post processing software have increased due to several advantages it provides. Although there are several benefits associated with this software, it comes with several disadvantages. Firstly, the health details of the patients can be gathered by hackers, thereby leading to security breaches. Secondly, this software may sometimes bring out incorrect results that may lead to wrong treatments. Thus, security breaches, along with malfunctioning of the software, are expected to restrain the market growth during the forecast period.
Opportunity
AI-based stroke detection software to reshape the industry
Advancements in science and technologies related to the development of software have gained traction at present. Nowadays, software developers are developing advanced stroke post processing software that is integrated with modern technologies such as AI and ML to deliver superior performance and results. Thus, the growing application of AI-enabled stroke detection software is expected to create ample growth opportunities for market players in the future.
The desktop segment held the largest market share in 2023. The rise in the number of hospitals across the world has increased the number of desktop installations for diagnostics and treatment purposes, thereby driving market growth. Also, desktops provide data storage and real-time tracking, as well as large storage space to store large amounts of data along with remote access to other devices, which is likely to boost market growth. Moreover, the development of advanced desktop-based stroke post processing software for the delivery of efficient and superior results is expected to propel the growth of the stroke post processing software market during the forecast period.
The mobile phones and tablets segment is expected to grow with the highest compound annual growth rate during the forecast period. The growing advancement in 5G technologies, coupled with the rising proliferation of smartphones across the world, is driving the market growth. Also, the portability offered by mobile phones and tablets, along with the rapid demand for virtual care services, has boosted the development of this industry. Moreover, the rising development in the IT sector has led software developers to design stroke post processing software for mobile phones and tablets, which is likely to drive the growth of the stroke post processing software market.
The MRI segment held a dominant share in 2023. The growing demand for magnetic resonance imaging machines in stroke detection applications due to their ability to provide accurate images of brains and arteries has driven the market growth. Also, the rising application of MRI scanners for the diagnosis and management of acute ischemic strokes has increased the demand for software associated with it, thereby driving the market growth. Moreover, the increasing demand for advanced MRI software for stroke diagnosis in hospitals is boosting the growth of the stroke post processing software market during the forecast period.
The CT scan segment is expected to attain the fastest CAGR during the forecast period. The rising application of CT scanners due to their ability to visualize the damage to the brain cells or bleeding in the brain from stroke attacks drives the market growth. Also, the diagnosis of stroke in humans can be made much more quickly in CT scanners than in MRI machines, which increases the demand for CT scan-based software, thereby driving market growth. Moreover, the rising development in the healthcare software industry related to the development of stroke post processing software has fostered the growth of the stroke post processing software market during the forecast period.
The ischemic stroke segment dominated the market in 2023. The growing number of government hospitals treating ischemic stroke has increased the demand for stroke post processing software, thereby driving the market growth. Moreover, the rising prevalence of ischemic stroke among people across the world has increased the demand for MRI and CT scanners for detection and treatment, thereby increasing demand for stroke post processing software associated with it, which in turn is expected to boost the growth of the stroke post processing software market during the forecast period.
The hemorrhagic stroke segment is estimated to grow with the highest CAGR during the forecast period. The rising advancements in MRI machines for detecting hemorrhagic stroke have increased the demand for MRI-based stroke detection software, thereby driving market growth. Also, the rising cases of hemorrhagic stroke across the world have increased the demand for early stroke detection software and hardware technologies that, in turn, drive the growth of the stroke post processing software market during the forecast period.
The hospitals and clinics segment held the largest share of the market in 2023. The rise in the number of public and private hospitals around the world that deal with the treatment of strokes has increased the demand for stroke post processing software, thereby driving market growth. Moreover, the increasing investment from the governments of several countries in strengthening the medical devices industry has boosted market growth. Additionally, the growing integration of technologies in diagnostic systems, such as computed tomography scanners and MRI systems, that are implanted in hospitals is driving the growth of the stroke post processing software market during the forecast period.
The specialty centers and other segments are expected to be the fastest growing segment during the forecast period. The rise in the number of specialty centers related to the treatment of ischemic stroke across the world is driving the market growth. Moreover, the growing trend of specialty centers due to their mobility and availability in remote places that help in diagnosing and treating stroke patients has boosted the growth of the stroke post processing software market during the forecast period.
Segments Covered in the Report
By Installation
By Modality
By Type
By End-use
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Stroke Post Processing Software Market
5.1. COVID-19 Landscape: Stroke Post Processing Software Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Stroke Post Processing Software Market, By Installation
8.1. Stroke Post Processing Software Market, by Installation, 2024-2033
8.1.1. Desktop
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Mobile Phones & Tablets
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Stroke Post Processing Software Market, By Modality
9.1. Stroke Post Processing Software Market, by Modality, 2024-2033
9.1.1. CT-Scan
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. MRI
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Stroke Post Processing Software Market, By Type
10.1. Stroke Post Processing Software Market, by Type, 2024-2033
10.1.1. Ischemic Stroke
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Hemorrhagic Stroke
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Others
10.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Stroke Post Processing Software Market, By End-use
11.1. Stroke Post Processing Software Market, by End-use, 2024-2033
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Specialty Centers & Others
11.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Stroke Post Processing Software Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Installation (2021-2033)
12.1.2. Market Revenue and Forecast, by Modality (2021-2033)
12.1.3. Market Revenue and Forecast, by Type (2021-2033)
12.1.4. Market Revenue and Forecast, by End-use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Installation (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Modality (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Type (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Installation (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Modality (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Type (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Installation (2021-2033)
12.2.2. Market Revenue and Forecast, by Modality (2021-2033)
12.2.3. Market Revenue and Forecast, by Type (2021-2033)
12.2.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Installation (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Modality (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Type (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Installation (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Modality (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Type (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Installation (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Modality (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Type (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Installation (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Modality (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Type (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Installation (2021-2033)
12.3.2. Market Revenue and Forecast, by Modality (2021-2033)
12.3.3. Market Revenue and Forecast, by Type (2021-2033)
12.3.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Installation (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Modality (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Type (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Installation (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Modality (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Type (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Installation (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Modality (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Type (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Installation (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Modality (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Type (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Installation (2021-2033)
12.4.2. Market Revenue and Forecast, by Modality (2021-2033)
12.4.3. Market Revenue and Forecast, by Type (2021-2033)
12.4.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Installation (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Modality (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Type (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Installation (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Modality (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Type (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Installation (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Modality (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Type (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Installation (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Modality (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Type (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Installation (2021-2033)
12.5.2. Market Revenue and Forecast, by Modality (2021-2033)
12.5.3. Market Revenue and Forecast, by Type (2021-2033)
12.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Installation (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Modality (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Type (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Installation (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Modality (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Type (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 13. Company Profiles
13.1. Brainomix
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Viz.Ai, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. ISchemaView, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Nicolab B.V.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. TeraRecon Inc
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Icometrix
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. RapidAI
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. CerebraAI
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Aidoc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Qure.ai
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client